{"id":69583,"date":"2025-02-25T00:00:00","date_gmt":"2025-02-25T00:00:00","guid":{"rendered":"https:\/\/www.pharmacie-vezere.com\/promotions\/la-fda-accorde-le-statut-de-priorite-a-pyx-201-de-pyxis\/"},"modified":"2025-02-25T00:00:00","modified_gmt":"2025-02-25T00:00:00","slug":"la-fda-accorde-le-statut-de-priorite-a-pyx-201-de-pyxis","status":"publish","type":"post","link":"https:\/\/www.pharmacie-vezere.com\/promotions\/la-fda-accorde-le-statut-de-priorite-a-pyx-201-de-pyxis\/","title":{"rendered":"La FDA accorde le statut de priorit\u00e9 \u00e0 PYX-201 de Pyxis."},"content":{"rendered":"<p>Deux essais cliniques impliquant l&#8217;ADC recrutent actuellement des participants. Cr\u00e9dits : PeopleImages.com \u2013 Yuri A\/Shutterstock.<\/p>\n<p>La Food and Drug Administration (FDA) des \u00c9tats-Unis a accord\u00e9 la d\u00e9signation de voie rapide \u00e0 l&#8217;anticorps-m\u00e9dicament conjugu\u00e9 (ADC) de Pyxis Oncology, PYX-201, pour traiter les adultes atteints de carcinome \u00e9pidermo\u00efde de la t\u00eate et du cou r\u00e9current ou m\u00e9tastatique (R\/M HNSCC). <\/p>\n<p>Ce traitement est destin\u00e9 aux personnes dont la maladie a progress\u00e9 apr\u00e8s un traitement par chimioth\u00e9rapie \u00e0 base de platine et un anticorps anti-ligand de la mort cellulaire programm\u00e9e (PD-L). PYX-201 cible le composant structurel non cellulaire Extradomain-B Fibronectin (EDB+FN) dans la matrice extracellulaire de la tumeur.<\/p>\n<p>Deux essais cliniques sont en cours de recrutement pour l&#8217;ADC. Le premier, PYX-201-101, \u00e9value l&#8217;ADC en tant qu&#8217;agent unique chez des patients atteints de cette condition. Le second, PYX-201-102, examine l&#8217;ADC en combinaison avec Keytruda (pembrolizumab) de MSD, chez des patients atteints de R\/M HNSCC ainsi que d&#8217;autres tumeurs solides avanc\u00e9es. Cet essai fait partie d&#8217;un accord de partenariat avec la soci\u00e9t\u00e9 biopharmaceutique MSD.<\/p>\n<p>Lara Sullivan, pr\u00e9sidente et PDG de Pyxis Oncology, a d\u00e9clar\u00e9 : \u00ab Recevoir la d\u00e9signation de voie rapide pour PYX-201 de la FDA marque une \u00e9tape importante pour Pyxis Oncology, reconnaissant notre potentiel \u00e0 r\u00e9pondre \u00e0 un besoin m\u00e9dical important dans le R\/M HNSCC. Cette d\u00e9signation souligne l&#8217;urgence d&#8217;apporter des options de traitement diff\u00e9renci\u00e9es aux patients et aidera \u00e0 acc\u00e9l\u00e9rer le d\u00e9veloppement de PYX-201 alors que nous recrutons des patients pour notre essai. Nous sommes impatients de travailler avec la FDA pour avancer cette th\u00e9rapie prometteuse aussi efficacement que possible. \u00bb<\/p>\n<p>Cette d\u00e9signation d\u00e9pend des donn\u00e9es montrant le potentiel du m\u00e9dicament \u00e0 r\u00e9pondre \u00e0 un besoin m\u00e9dical non satisfait pour la condition cibl\u00e9e.<\/p>\n<p>Le carcinome \u00e9pidermo\u00efde, un sous-type de cancer de la t\u00eate et du cou, provient de la muqueuse de la cavit\u00e9 buccale.<\/p>\n<p>En mai 2023, Pyxis a conclu un accord d\u00e9finitif pour acheter Apexigen dans le cadre d&#8217;un accord de 16 millions de dollars.<\/p>\n<p>Inscrivez-vous \u00e0 notre bulletin d&#8217;information quotidien !<br \/>\nDonnez \u00e0 votre entreprise un avantage avec nos informations de pointe dans l&#8217;industrie.<br \/>\nInscrivez-vous<br \/>\nPartagez<\/p>\n","protected":false},"excerpt":{"rendered":"<p>La th\u00e9rapie est destin\u00e9e aux personnes dont la maladie a progress\u00e9 apr\u00e8s un traitement de chimioth\u00e9rapie \u00e0 base de platine.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[1],"tags":[],"class_list":["post-69583","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/posts\/69583","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/comments?post=69583"}],"version-history":[{"count":0,"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/posts\/69583\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/media?parent=69583"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/categories?post=69583"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/tags?post=69583"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}